Bondi Terror Attack Survivor's Account on Baffling Police Response Will Leave You Seething
CNN Analyst Had a Brutal Line About the Dems' Approval Ratings
Trump's 'Patriot Games' Has Launched Yet Another Leftist Meltdown
Trump Administration Takes Huge Action Against These States Over Voter Data
The Trump Administration Just Suspended This Immigration Program After Brown University Sh...
Defending Education Files Title VI Complaint Against Portland Public Schools
J.K. Rowling Notices Labour's Misogyny Hypocrisy
Oh, Really? This Georgia County Admitted It Didn't Follow the Rules During the...
Biden's FTC Chair Just Handed China Another Win
When Veterans Have to Break the Law to Heal, the Law Is Broken
Ben Shapiro Delivers a Fiery Moral Reckoning During His AmericaFest Speech
Dem Senate Candidate Says She Wouldn't Be Able to Control Herself, Would Assault...
Jasmine Crocket Would Make Kamala Harris Proud With Her Latest Word Salad
Erika Kirk and TPUSA Endorse JD Vance for 2028 at AmericaFest
FBI Charges Chinese National With Smuggling Deadly Bacteria Into US
Tipsheet

The Gambling Gamble Falls to Weather in Asia

Welcome to John Ransom’s Stocks in the News where the headlines meet the trendlines.

Stock number one: Gigamon Inc.

Gigamon slips after missed deal prompts lower Q1 outlook—Fly on the Wall

Advertisement

Shares of Gigamon (GIMO), which offers solutions to control and manage network traffic, are slipping after the company lowered its first quarter revenue outlook based on the fall-out of a large deal with an existing customer. WHAT'S NEW: Last night, Gigamon reduced its first quarter revenue view to $31M-$31.5M from its previous outlook of $34M-$35M. Prior to the company's warning, analysts consensus revenue estimate was $34.8M. The company attributed the lowered revenue to one expected large transaction from an existing customer in EMEA that did not transpire.

Symbol: GIMO

Trailing PE: NA; Forward PE: 24

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Sell Gigamon

GIMO Chart

GIMO data by YCharts

Stock number two: Mallinckrodt plc

Drug Deals Surge to New High With Mallinckrodt: Real M&A—Barron's

Mallinckrodt (MNK) Plc said yesterday that it will buy Questcor Pharmaceuticals Inc. for $5.6 billion. That propelled the amount spent on specialty drugmaker deals in the past year to almost $60 billion, the most for a 12-month period since December 2009, according to data compiled by Bloomberg. Drugmakers from Actavis Plc to Valeant Pharmaceuticals International Inc. (VRX) -- and now Mallinckrodt -- are broadening their suites of drugs through takeovers that immediately boost earnings with the help of lower corporate tax rates in countries such as Ireland.

Advertisement

Symbol: MNK

Trailing PE: 43 Forward PE: 19

PEG: 2.67

Dividend: NA

Estimate Trend: Up

Ransom Note Trendline: Hold Mallinckrodt

MNK Chart

MNK data by YCharts

Stock number three: Caesars Entertainment Corporation

Online Gambling May Not Be the Best Bet-- Motley Fool

Las Vegas Sands, MGM Resorts International, Wynn Resorts, Melco Crown Entertainment and other Macau casino companies fell hard early Monday on a report that total gambling revenue so far in April is below forecasts because of rugged weather. Caesars Entertainment (CZR), which doesn't own casinos in Asia but is the largest U.S. casino operator, was down 2%.

Symbol: CZR

Trailing PE: NA; Forward PE: NA

PEG: NA

Dividend: NA

Estimate Trend: Flat

Ransom Note Trendline: Avoid Caesars Entertainment

DO Chart

DO data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos